Application 207797

Type
ANDA
Sponsor
CHARTWELL RX

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 1.5MG BASENoNo
002RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 3MG BASENoNo
003RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 4.5MG BASENoNo
004RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 6MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
27241-090RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEAjanta Pharma LimitedANDACurrent
27241-091RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEAjanta Pharma LimitedANDACurrent
27241-092RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEAjanta Pharma LimitedANDACurrent
27241-093RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEAjanta Pharma LimitedANDACurrent